• OPEN AN ACCOUNT
Indian Indices
Nifty
25,492.30 -17.40
(-0.07%)
Sensex
83,216.28 -94.73
( -0.11%)
Bank Nifty
57,876.80 322.55
( 0.56%)
Nifty IT
35,117.65 -219.95
( -0.62%)
Global Indices
Nasdaq
16.76 83.45
(0.18%)
Dow Jones
6,751.11 9.79
(0.15%)
Hang Seng
50,211.07 -672.61
(-1.32%)
Nikkei 225
9,688.02 -47.76
(-0.49%)
Forex
USD-INR
88.62 -0.02
(-0.03%)
EUR-INR
102.12 0.31
(0.30%)
GBP-INR
116.02 0.48
(0.42%)
JPY-INR
0.58 0.00
(0.14%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
30.5295026
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
40.52
8281.57
EPS(TTM)
Face Value()
Div & Yield %
4.51
1
0.44
 

Elantas Beck India Ltd - Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015
Oct 04,2025
In continuation of our earlier communications this is to inform that Gujarat Pollution Control Board ('GPCB') has granted a further extension of one year to the revocation of the closure order issued to the Companys manufacturing plant located at GIDC Ankleshwar Dist. Bharuch Gujarat. In compliance of the GPCB order ELANTAS industrial plant at Ankleshwar Bharuch will continue to operate.